BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lo MS. Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus. Front Immunol 2018;9:1278. [PMID: 29922296 DOI: 10.3389/fimmu.2018.01278] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Gupta A. Updates on Pediatric Rheumatologic Diseases. Common Pediatric Diseases: an Updated Review 2022. [DOI: 10.2174/9789815039658122010006] [Reference Citation Analysis]
2 Jourde-chiche N, Daniel L, Chiche L, Bertin D, Dumestre-pérard C, Burtey S, Bardin N. Rôle du complément dans la néphropathie lupique et la néphropathie du syndrome des anti-phospholipides. La Presse Médicale Formation 2022;3:156-163. [DOI: 10.1016/j.lpmfor.2022.03.007] [Reference Citation Analysis]
3 Mathapathi S, Chu C. Contribution of impaired DNASE1L3 activity to anti-DNA autoantibody production in systemic lupus erythematosus. Rheumatology and Immunology Research 2022;3:17-22. [DOI: 10.2478/rir-2022-0003] [Reference Citation Analysis]
4 Ferreté-Bonastre AG, Cortés-Hernández J, Ballestar E. What can we learn from DNA methylation studies in lupus? Clin Immunol 2022;234:108920. [PMID: 34973429 DOI: 10.1016/j.clim.2021.108920] [Reference Citation Analysis]
5 Cody EM, Brunner HI. Biomarkers in Childhood-Onset Systemic Lupus Erythematosus. Rheum Dis Clin North Am 2022;48:271-85. [PMID: 34798952 DOI: 10.1016/j.rdc.2021.09.003] [Reference Citation Analysis]
6 Kisla Ekinci RM, Balci S, Ozcan D, Atmis B, Bisgin A. Monogenic lupus due to DNASE1L3 deficiency in a pediatric patient with urticarial rash, hypocomplementemia, pulmonary hemorrhage, and immune-complex glomerulonephritis. Eur J Med Genet 2021;64:104262. [PMID: 34161863 DOI: 10.1016/j.ejmg.2021.104262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jiang J, Zhao M, Chang C, Wu H, Lu Q. Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases. Clin Rev Allergy Immunol 2020;59:248-72. [PMID: 32557263 DOI: 10.1007/s12016-020-08798-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 19.0] [Reference Citation Analysis]
8 Al-Mayouf SM, Alreefi HA, Alsinan TA, AlSalmi G, AlRowais A, Al-Herz W, Alazami AM, Alsonbul A, Al-Mousa H. Lupus manifestations in children with primary immunodeficiency diseases: Comprehensive phenotypic and genetic features and outcome. Mod Rheumatol 2021;:1-16. [PMID: 33563058 DOI: 10.1080/14397595.2021.1886627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Trindade VC, Carneiro-Sampaio M, Bonfa E, Silva CA. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus. Paediatr Drugs 2021;23:331-47. [PMID: 34244988 DOI: 10.1007/s40272-021-00457-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]